These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 15925263)
1. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. Rukstalis M; Jepson C; Patterson F; Lerman C J Subst Abuse Treat; 2005 Jun; 28(4):297-304. PubMed ID: 15925263 [TBL] [Abstract][Full Text] [Related]
2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial. Shiffman S Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988 [TBL] [Abstract][Full Text] [Related]
3. Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. Fuemmeler BF; Kollins SH; McClernon FJ J Pediatr Psychol; 2007; 32(10):1203-13. PubMed ID: 17602186 [TBL] [Abstract][Full Text] [Related]
4. High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes. Kalman D; Kahler CW; Garvey AJ; Monti PM J Subst Abuse Treat; 2006 Apr; 30(3):213-7. PubMed ID: 16616165 [TBL] [Abstract][Full Text] [Related]
5. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Kollins SH; McClernon FJ; Fuemmeler BF Arch Gen Psychiatry; 2005 Oct; 62(10):1142-7. PubMed ID: 16203959 [TBL] [Abstract][Full Text] [Related]
6. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [TBL] [Abstract][Full Text] [Related]
17. Smoking rates and topography predict adolescent smoking cessation following treatment with nicotine replacement therapy. Franken FH; Pickworth WB; Epstein DH; Moolchan ET Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):154-7. PubMed ID: 16434603 [TBL] [Abstract][Full Text] [Related]
18. The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination. Gehricke JG; Whalen CK; Jamner LD; Wigal TL; Steinhoff K Nicotine Tob Res; 2006 Feb; 8(1):37-47. PubMed ID: 16497598 [TBL] [Abstract][Full Text] [Related]
19. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. Ray R; Jepson C; Wileyto EP; Dahl JP; Patterson F; Rukstalis M; Pinto A; Berrettini W; Lerman C Nicotine Tob Res; 2007 Nov; 9(11):1237-41. PubMed ID: 17978999 [TBL] [Abstract][Full Text] [Related]
20. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Becker KM; Rose JE; Albino AP Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]